Condensed Consolidated Statements of Cash Flows (USD $) In Thousands	9 Months Ended
	Jun. 30, 2011	Jun. 30, 2010 Predecessor
Cash flows from operating activities:
Net (loss) income	$ (7,970)	$ 188,425
Adjustments to reconcile net (loss) income to net cash and cash equivalents provided by operating activities:
Impairments and disposals of assets	2,039	10,033
Depreciation and amortization	76,572	50,071
Foreign currency transaction (gain) loss	(1,519)	1,312
Amortization of deferred charges	11,247	1,093
Write off of financing fees	20,824
Stock-based compensation	798	5,308
Allowance for doubtful accounts	5,458	1,977
Amortization of incremental inventory fair value	122,104
Inventory reserves	23,086	3,317
Deferred income taxes	(42,059)	2,048
Excess income tax benefit from exercise of stock options		(6,097)
Changes in operating assets and liabilities:
Accounts receivable	(10,472)	8,770
Inventories	(23,460)	6,445
Other assets	17,009	12,036
Accounts payable	(15,944)	(21,358)
Accrued expenses and other liabilities	(7,472)	7,335
Net cash provided by operating activities	170,241	270,715
Cash flows from investing activities:
Purchase of property, plant and equipment	(35,481)	(40,358)
Proceeds from sale of available-for-sale investments		2,000
Cash paid for acquisitions	(3,986,074)	(11,875)
Net cash used in investing activities	(4,021,555)	(50,233)
Cash flows from financing activities:
Principal payments under long-term debt agreements and capital leases	(9,569)	(42,992)
Payments for financing fees	(138,227)
Proceeds from borrowings	2,400,000
Capital contribution	1,550,400
Excess income tax benefit from exercise of stock options		6,097
Proceeds from stock options exercised		10,324
Net cash provided by (used in) financing activities	3,802,604	(26,571)
Effect of exchange rate changes on cash and cash equivalents	2,602	(6,280)
Net (decrease) increase in cash and cash equivalents	(46,108)	187,631
Cash and cash equivalents at beginning of period	346,483	106,001
Cash and cash equivalents at end of period	$ 300,375	$ 293,632